NCT04282213

Brief Summary

Mechanomyography (MMG) is considered the gold-standard for neuromuscular blockade (NMB) monitoring. However, it is quite bulky and difficult to use on a routine basis. Therefore, alternative methods like Acceleromyography (AMG), Electromyography (EMG) and the TOF-CUFF method have been developed. The aim of this study was to compare the TOF-Cuff monitor and Electromyography (EMG-NMT module with the CARESCAPE B450 monitor) data following rocuronium-induced neuromuscular blockade and its reversal.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
32

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jan 2020

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 15, 2020

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

February 19, 2020

Completed
5 days until next milestone

First Posted

Study publicly available on registry

February 24, 2020

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 10, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 10, 2020

Completed
Last Updated

September 22, 2021

Status Verified

September 1, 2021

Enrollment Period

4 months

First QC Date

February 19, 2020

Last Update Submit

September 21, 2021

Conditions

Outcome Measures

Primary Outcomes (10)

  • TOFR (Train Of Four Ratio)

    For this measurement, patient is stimulated with four twitches at a known stimulation current. Each twitch is performed every 500ms. The neuromuscular response for each twitch is gathered. Train Of Four ratio consists of the weighting of the fourth stimulus against the first stimulus. It can be calculated also as a percentage.

    Baseline

  • Counts

    When performing the Train Of Four (TOF) measurement, count of the twitches that are higher than 0.

    Baseline

  • PTC

    Once patient is in a deep neuromuscular blockade, all twitches from Train Of Four (TOF) measurement are 0. In order to evaluate the neuromuscular response, Post Tetanic Count (PTC) measurement is performed. PTC is splitted in two steps. First, during 5 seconds a tetanic stimulation is performed at 50Hz. If no response is elicited, after a pause of 3 seconds 15 single-twitch stimualtion at 1Hz are performed. PTC value is the count of the single-twitches that are higher than 0.

    Baseline

  • T1

    For Train Of Four (TOF) measurement, amplitude of the first neuromuscular stimulation response. Units depend on the measurement techniques.

    Baseline

  • T2

    For Train Of Four (TOF) measurement, amplitude of the second neuromuscular stimulation response. Units depend on the measurement techniques.

    Baseline

  • T3

    For Train Of Four (TOF) measurement, amplitude of the third neuromuscular stimulation response. Units depend on the measurement techniques.

    Baseline

  • T4

    For Train Of Four (TOF) measurement, amplitude of the fourth neuromuscular stimulation response. Units depend on the measurement techniques.

    Baseline

  • PID

    Diastolic pressure in mmHg

    Baseline

  • PIS

    Systolic pressure in mmHg

    Baseline

  • PIM

    Mean pressure in mmHg

    Baseline

Secondary Outcomes (1)

  • Temperature

    Baseline

Study Arms (2)

Control samples

For each case, neuromuscular measurements gathered with GE CARESCAPE B450 monitor (E-NMT module).

Case samples

For each case, neuromuscular measurements gathered with TOFCuff monitor.

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients American Society of Anesthesiologist (ASA) I-II, between 18-65 years and scheduled for elective surgery under general anesthesia.

You may qualify if:

  • ASA I-II
  • Patients who give their written informed consent
  • Elective surgery under general anesthesia that according to the anesthetic plan muscle relaxants will be administered

You may not qualify if:

  • Patients who refuse to give their informed consent
  • Patients who present any of the contraindications for the devices used in the study
  • Women of childbearing age who do not use effective contraceptive methods, pregnant women, with suspicion of pregnancy or breast-feeding
  • Patients with the following criteria: upper limb peripheral vascular pathologies, a difficult airway, myasthenia gravis and other neuromuscular diseases, use of medication that may alter NMT

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Centro Médico Teknon

Barcelona, 08022, Spain

Location

Related Publications (5)

  • Naguib M, Kopman AF, Lien CA, Hunter JM, Lopez A, Brull SJ. A survey of current management of neuromuscular block in the United States and Europe. Anesth Analg. 2010 Jul;111(1):110-9. doi: 10.1213/ANE.0b013e3181c07428. Epub 2009 Nov 12.

    PMID: 19910616BACKGROUND
  • Veiga Ruiz G, Garcia Cayuela J, Orozco Montes J, Parreno Caparros M, Garcia Rojo B, Aguayo Albasini JL. Monitoring intraoperative neuromuscular blockade and blood pressure with one device (TOF-Cuff): A comparative study with mechanomyography and invasive blood pressure. Rev Esp Anestesiol Reanim. 2017 Dec;64(10):560-567. doi: 10.1016/j.redar.2017.03.013. Epub 2017 Jun 27. English, Spanish.

    PMID: 28662770BACKGROUND
  • Rodiera J, Serradell A, Alvarez-Gomez JA, Aliaga L. The cuff method: a pilot study of a new method of monitoring neuromuscular function. Acta Anaesthesiol Scand. 2005 Nov;49(10):1552-8. doi: 10.1111/j.1399-6576.2005.00777.x.

    PMID: 16223405BACKGROUND
  • Checketts MR, Jenkins B, Pandit JJ. Implications of the 2015 AAGBI recommendations for standards of monitoring during anaesthesia and recovery. Anaesthesia. 2017 Jan;72 Suppl 1:3-6. doi: 10.1111/anae.13736. No abstract available.

    PMID: 28044335BACKGROUND
  • Dahaba AA, von Klobucar F, Rehak PH, List WF. The neuromuscular transmission module versus the relaxometer mechanomyograph for neuromuscular block monitoring. Anesth Analg. 2002 Mar;94(3):591-6; table of contents. doi: 10.1097/00000539-200203000-00021.

    PMID: 11867381BACKGROUND

Study Officials

  • Lorena Silva Gil, MD

    Servei d'Anestesiologia Centro Médico Teknon

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

February 19, 2020

First Posted

February 24, 2020

Study Start

January 15, 2020

Primary Completion

May 10, 2020

Study Completion

May 10, 2020

Last Updated

September 22, 2021

Record last verified: 2021-09

Data Sharing

IPD Sharing
Will not share

Locations